www.drugs.com/history/arcoxia.html
Arcoxia FDA Approval Status Arcoxia (etoricoxib) is a selective COX-2 inhibitor for treatment of osteoarthritis. In April 2007, Merck & Co., Inc. announced the receipt of a Not Approvable Letter from the U.S. Food and Drug Administration (FDA), advising the company that the New Drug Application...